Although TGFβ exhibits tumor suppressor activity in pre-malignant lesions, there was no evidence of accelerated tumor growth due to blocking its effects in these advanced cancers, although this would be difficult to detect in a phase I study. The gene discussed is TGFB1; the disease is neoplasm.